Overview

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.
Phase:
Phase 1
Details
Lead Sponsor:
American Heart Association
Collaborator:
Eli Lilly and Company
Treatments:
Insulin
Insulin, Globin Zinc